Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice.
about
Non-invasive MRI and spectroscopy of mdx mice reveal temporal changes in dystrophic muscle imaging and in energy deficitsPKC theta ablation improves healing in a mouse model of muscular dystrophy.Molecular diagnosis of duchenne muscular dystrophy: past, present and future in relation to implementing therapiesInterleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype.Probing the stability of the "naked" mucin-like domain of human α-dystroglycanSimvastatin reduces fibrosis and protects against muscle weakness after massive rotator cuff tear.Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx miceOsteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophyElevated levels of active matrix metalloproteinase-9 cause hypertrophy in skeletal muscle of normal and dystrophin-deficient mdx mice.IFN-γ promotes muscle damage in the mdx mouse model of Duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibiting muscle cell proliferationMetalloproteinase expression is altered in cardiac and skeletal muscle in cancer cachexiaFine-structural distribution of MMP-2 and MMP-9 activities in the rat skeletal muscle upon training: a study by high-resolution in situ zymographyMolecular and cellular mechanisms of skeletal muscle atrophy: an update.Serological muscle loss biomarkers: an overview of current concepts and future possibilitiesNovel compounds for the treatment of Duchenne muscular dystrophy: emerging therapeutic agentsWasting mechanisms in muscular dystrophy.Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Inflammation and Fibrosis of Skeletal MusclesCell-matrix interactions in muscle disease.Therapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophy.Pathoproteomic profiling of the skeletal muscle matrisome in dystrophinopathy associated myofibrosis.Diaphragm degeneration and cardiac structure in mdx mouse: potential clinical implications for Duchenne muscular dystrophy.Intracellular MMP-2 activity in skeletal muscle is associated with type II fibers.Reciprocal interaction between TRAF6 and notch signaling regulates adult myofiber regeneration upon injuryNeo-epitope Peptides as Biomarkers of Disease Progression for Muscular Dystrophies and Other Myopathies.Connective tissue cells expressing fibro/adipogenic progenitor markers increase under chronic damage: relevance in fibroblast-myofibroblast differentiation and skeletal muscle fibrosis.Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.MMP-10 is required for efficient muscle regeneration in mouse models of injury and muscular dystrophy.MicroRNA-431 accelerates muscle regeneration and ameliorates muscular dystrophy by targeting Pax7 in mice.
P2860
Q28544896-5737C132-DDFB-469B-BB12-3F8053FA8378Q34163572-E2E5017F-2E0E-4B9F-AD94-5F0FD2C85C4EQ34215825-F8E56969-8A63-4A59-A29F-33998FB4E5AEQ34505654-EFD35751-A287-411B-B51E-CC935A13BC1BQ34788338-2CE07F54-1D07-46F0-BCCB-E221FE020FF5Q34921512-71858E26-F37D-417B-9F30-7A529AC9EC22Q34973330-CBCC5C09-1E03-4E4C-ABA9-E1D2331A1852Q35175749-8533173E-120F-403F-B756-F7D85E816130Q35389391-F327071A-6345-4F9E-9CB6-1C259B71FB08Q35523128-CD0F180A-9B8A-4B26-93D4-3D389ACB97DEQ35958613-DF1E198E-D160-42BD-BC4D-C2670F0DC003Q36028551-CA43FA57-9296-4FBB-B49B-5F782E976F94Q36179105-0A3D7627-AAD3-485B-9375-5C8943B64F0DQ36636397-F449099B-7F00-4CC2-B68F-ED0BD37F0F69Q36925191-0FC5E06A-72DB-4839-8F58-A9ADBBCB22D0Q37138490-7437E3C3-5D0C-4E03-902A-55E31070EB48Q37589790-FA8846F8-BE58-408A-9F7B-A6341F04C872Q37944530-C020AD39-4B69-4DA0-9BFE-EAE78BE5A60FQ38264461-06349649-D729-481C-9E64-0B70321B47EDQ38563300-AA0B62F5-C8DA-415B-8070-BE1831CC327CQ38914933-4ECC90FD-3052-4988-ACEB-D27AE4F3E8A4Q38987532-103BE5D7-EA5F-41E2-A106-5931AC0E64B1Q41170120-5E20B0C7-44D5-4D83-BB91-A95596F5416EQ42363358-370F01B9-F148-490C-AAD5-BFE242EB3D76Q44783314-FCC443D6-ED9A-4929-8145-222B7FC0F085Q45050237-01F351DD-BA0D-4CF7-A0C3-A3503245DDD5Q53086675-5E770B76-101C-41E1-BF10-8A99C88C5BEBQ53436627-7365C47F-49D9-474D-9165-E545826B4E2B
P2860
Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Matrix metalloproteinase inhib ...... dystrophin-deficient mdx mice.
@ast
Matrix metalloproteinase inhib ...... dystrophin-deficient mdx mice.
@en
type
label
Matrix metalloproteinase inhib ...... dystrophin-deficient mdx mice.
@ast
Matrix metalloproteinase inhib ...... dystrophin-deficient mdx mice.
@en
prefLabel
Matrix metalloproteinase inhib ...... dystrophin-deficient mdx mice.
@ast
Matrix metalloproteinase inhib ...... dystrophin-deficient mdx mice.
@en
P2093
P2860
P1476
Matrix metalloproteinase inhib ...... dystrophin-deficient mdx mice.
@en
P2093
Akhilesh Kumar
Ashok Kumar
Shephali Bhatnagar
P2860
P304
P356
10.2353/AJPATH.2010.091176
P407
P577
2010-05-14T00:00:00Z